Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation

Psychopharmacology

Volumn 156, Issue 2-3, 2001, Pages 338-351

  Heidbreder, Christian A ^a   Foxton, Richard ^a   Cilia, Jackie ^a   Hughes, Zoe A ^a   Shah, Ajit J ^a   Atkins, Alan ^a   Hunter, Jackie A ^a   Hagan, Jim J ^a   Jones, Declan N ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Amino acid; Antipsychotic drug; Dopamine; Medial prefrontal cortex; PPI; Social isolation syndrome

Indexed keywords

4 AMINOBUTYRIC ACID; ALANINE; AMINO ACID; ASPARTIC ACID; CLOZAPINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; GLUTAMIC ACID; GLUTAMINE; HALOPERIDOL; HISTIDINE; NEUROLEPTIC AGENT; OLANZAPINE; SEROTONIN 1A RECEPTOR; TYROSINE;

AMINO ACID BRAIN LEVEL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; AUDITORY STIMULATION; BRAIN REGION; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; HYPERACTIVITY; MALE; NEUROCHEMISTRY; NONHUMAN; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RAT; REARING; SOCIAL ISOLATION; STARTLE REFLEX;

AMINO ACIDS; ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLOZAPINE; DOPAMINE; EXCITATORY AMINO ACIDS; HALOPERIDOL; INDICATORS AND REAGENTS; MALE; MICRODIALYSIS; PIRENZEPINE; PREFRONTAL CORTEX; RATS; SOCIAL ISOLATION; STARTLE REACTION;

EID: 0034923413     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100760     Document Type: Article

References (89)

1. Prevention by (±)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol
2. Clozapine and haloperidol modulate N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro
3. Reversal of isolation rearing-induced deficits in prepulse inhibition by seroquel and olanzapine
4. Glutamate agonist activity: Implications for antipsychotic drug action and schizophrenia
5. Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind trial
6. The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia
7. Gating and habituation of the startle reflex in schizophrenic patients
8. Symptom correlates of prepulse inhibition deficits in normal and schizophrenic patients
9. Radioreceptor binding profile of the atypical antipsychotic olanzapine
10. Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia
11. Extrapyramidal syndromes: Primate models as predictors of clinical response
12. A Canadian multicentre placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of schizophrenic patients
13. Reversal of haloperidol-induced extrapyramidal side effects in Cebus monkeys by 8-hydroxy-2-(di-n-propylamino)tetraline and its enantiomers
14. Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats
15. Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats
16. Dopamine in schizophrenia: A review and reconceptualization
17. Reduced hippocampal N-acetylaspartate without volume loss in schizophrenia
18. The disruption of prepulse inhibition by social isolation in the Wistar rat: How robust is the effect?
19. The effects of an early stressful life event on sensorimotor gating in adult rats
20. Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia
21. 2C receptor responsiveness occurs on rearing rats in social isolation
22. Conditioned release of 5-hydroxytryptamine in vivo in the nucleus accumbens following isolation-rearing in the rat
23. Glutamate, nitric oxide and cell-cell signalling in the nervous system
24. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons in the prefrontal cortex
25. Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia
26. Glutamate and schizophrenia: Clinical and research implications
27. Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
28. Startle gating deficits occur across prepulse intensities in schizophrenic patients
29. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine
30. Olanzapine versus placebo and haloperidol: Quality of life and efficacy results of the North American double-blind trial
31. Behavioral, neurochemical, and endocrinological characterization of the early social isolation syndrome
32. 2 adrenoreceptor blockade
33. Leftward shift in the acquisition of cocaine self-administration in isolation-reared rats: Relationship to extracellular levels of dopamine, serotonin and glutamate in the nucleus accumbens and amygdala-striatal FOS expression
34. 1A receptor activation
35. 3H]GABA release from chick retina cells
36. 1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis
37. Dopaminergic and serotonergic function following isolation rearing in rats: Study of behavioural responses and postmortem and in vivo neurochemistry
38. Clozapine for the treatment-resistant schizophrenic
39. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens
40. Neuroleptic drugs alter the dopamine transporter-mediated uptake and release of dopamine: A possible mechanism for drug-induced tardive dyskinesia
41. Intracellular modulation of NMDA receptor function by antipsychotic drugs
42. Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum
43. To model a psychiatric disorder in animals: Schizophrenia as a reality test
44. 3H]norepinephrine release. I. The role of glutamate
45. Nitric oxide induces neurotransmitter release from hippocampal slices
46. 3H]dopamine release from striatal slices
47. 2A/2C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release
48. Clozapine potently stimulates mesocortical dopamine neurons
49. The concept of atypical antipsychotics
50. The role of serotonin in antipsychotic drug action
51. i values
52. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: An in vivo microdialysis study
53. Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex
54. Noradrenergic innervation patterns in three regions of medial cortex: An immunofluorescence characterization
55. 1A receptors
56. Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex
57. Clozapine- and olanzapine-induced Fos expression in the rat medial prefrontal cortex is mediated by b-adrenoreceptors
58. 3H]GABA release from cerebral cortical neurons is mediated by peroxynitrite
59. 3H]-aminobutyric acid release is mediated by two distinct release mechanisms
60. The role of glutamate receptors in antipsychotic drug action
61. Impaired prepulse inhibition of acoustic startle in schizophrenia
62. Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen
63. Behavioural and neurochemical effects of early social deprivation in the rat
64. 1A receptor activation
65. 1A receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex
66. 1 dopamine receptors in prefrontal cortex: Involvement in working memory
67. Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding
68. Nitric oxide and synaptic function
69. Ziprasidone (CP-88,059), a new antipsychotic with combined dopamine and serotonin receptor antagonist activity
70. Nitric oxide regulates excitatory amino acid release in a biphasic manner in freely moving rats
71. N-Acetyl-aspartylglutamate suppresses the climbing fiber response of Purkinje cells in guinea pigs cerebellar slices and the responses to excitatory amino acids of Xenopus laevis oocytes injected with cerebellar mRNA
72. Tyrosine administration augments clozapine-induced dopamine release in the medial prefrontal cortex of the rat: Parametric influences
73. Differential effects of haloperidol and clozapine on ionotropic glutamate receptors in rats
74. 3H]dopamine from rat striatum in vitro
75. Ziprasidone: A novel antipsychotic with unique pharmacology and therapeutic potential
76. Negative symptoms: A path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine
77. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains
78. Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy
79. Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs
80. BIMG80, a novel potential antipsychotic drug: Evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex
81. Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: Enhancement of antipsychotic-like effects without catalepsy
82. 1A receptors in the rat prefrontal cortex
83. Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients
84. Cortical maldevelopment, antipsychotic drugs, and schizophrenia: A search for common ground
85. Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain
86. Social isolation in the rat produces developmentally specific deficits in prepulse inhibition of the acoustic startle response without disrupting latent inhibition
87. Effect of isolation-rearing on 5-HT agonist-induced responses in the rat
88. Clozapine preferentially increases dopamine release in the rhesus monkey prefrontal cortex compared with the caudate nucleus